This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samuel, C. S. Articles by Tang, M. L. K. Search for Related Content PubMed PubMed Citation Articles by Samuel, C. S. Articles by Tang, M. L. K.

Relaxin Plays an Important Role in the Regulation of Airway Structure and Function

Howard Florey Institute of Experimental Physiology and Medicine (C.S.S., C.Z., G.W.T.) and Department of Biochemistry and Molecular Biology (C.S.S., G.W.T.), The University of Melbourne, Parkville, Victoria 3010, Australia; and Department of Allergy and Immunology (S.G.R., M.D.B., M.L.K.T.), Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Victoria 3052, Australia

Address all correspondence and requests for reprints to: Associate Professor Mimi L. K. Tang, M.D., Ph.D., Department of Allergy and Immunology, Royal Children’s Hospital, Parkville, Victoria 3052, Australia. E-mail: mimi.tang{at}rch.org.au.

Relaxin is a reproductive hormone with pleiotropic actions. In addition to airway fibrosis, relaxin deficiency results in airway structural changes (epithelial thickening) and increased lung recoil, suggesting that relaxin may impact other aspects of airway/lung structure and function beyond its ability to regulate collagen turnover. Furthermore, these structural changes associated with relaxin deficiency show marked similarity to the structural changes seen in asthma. The current study investigated the broader role of relaxin in regulating airway structure and function and examined the relationship between airway inflammation, structural changes, and airway hyperresponsiveness (AHR) using an ovalbumin (OVA)-induced model of allergic airways disease (AAD). The model of AAD was applied to 12-month-old relaxin-deficient (Rln^–/–) mice with established airway fibrosis and age-matched wild-type (Rln^+/+) controls. OVA-treated Rln^+/+ mice (induced inflammation) developed increased epithelial thickening (P < 0.05) and AHR (P < 0.05) but not airway fibrosis, compared with saline-treated Rln^+/+ controls. Saline-treated Rln^–/– mice had significantly increased lung collagen deposition (existing fibrosis) and epithelial thickening and remarkably were found to have increased AHR that was equivalent to that in OVA-treated Rln^+/+ mice (all P < 0.05 vs. saline-treated Rln^+/+ controls). OVA-treated Rln^–/– mice (existing fibrosis and induced inflammation) had increased airway/lung fibrosis (P < 0.05) but equivalent airway inflammation and AHR compared with OVA-treated Rln^+/+ animals. These findings demonstrate for the first time a role for relaxin in the regulation of airway responses using Rln^–/– mice and suggest that airway fibrosis and/or epithelial thickening can result in increased AHR equivalent to that induced by airway inflammation in AAD.

This article has been cited by other articles:

				S. G. Royce, Y. R. Miao, M. Lee, C. S. Samuel, G. W. Tregear, and M. L. K. Tang Relaxin Reverses Airway Remodeling and Airway Dysfunction in Allergic Airways Disease Endocrinology, June 1, 2009; 150(6): 2692 - 2699. [Abstract] [Full Text] [PDF]

				C. S. Samuel, S. G. Royce, B. Chen, H. Cao, J. A. Gossen, G. W. Tregear, and M. L. K. Tang Relaxin Family Peptide Receptor-1 Protects against Airway Fibrosis during Homeostasis But Not against Fibrosis Associated with Chronic Allergic Airways Disease Endocrinology, March 1, 2009; 150(3): 1495 - 1502. [Abstract] [Full Text] [PDF]